Schüz-Henninger R, Prinz C, Decker K
Biochemisches Institut, Albert-Ludwigs-Universität, Freiburg i.Br., Federal Republic of Germany.
Arch Biochem Biophys. 1988 Apr;262(1):49-58. doi: 10.1016/0003-9861(88)90167-1.
Several glycosyltransferases participating in ganglioside biosynthesis were measured in Golgi-rich fractions from rat liver. Addition of those UDP-amino sugars to the enzyme assays which accumulate in liver after treatment of rats with D-galactosamine inhibited the transferases to different degrees. The simultaneous presence of UDP-GalN, UDP-GalNAc, UDP-GlcN, and UDP-GlcNAc in concentrations resembling their overall content in livers 6 h after D-galactosamine administration led to an inhibition of the glycolipid galactosyltransferases, GL2 and GM1 synthases of 44 and 64%, respectively. GM2 synthase was moderately inhibited whereas the sialyltransferases (GM3, GD3, and GD1a synthases) were almost unimpaired. Induction of liver cell damage by D-galactosamine did not cause any change of glycosyltransferase activities as determined in rat liver homogenates and Golgi-rich fractions. These results indicate a possible role for UDP-amino sugars in the depression of ganglioside biosynthesis observed in vivo after GalN administration.
在大鼠肝脏富含高尔基体的组分中,检测了几种参与神经节苷脂生物合成的糖基转移酶。在用D-半乳糖胺处理大鼠后,肝脏中积累的那些UDP-氨基糖添加到酶分析中,不同程度地抑制了这些转移酶。在给予D-半乳糖胺6小时后,UDP-GalN、UDP-GalNAc、UDP-GlcN和UDP-GlcNAc以类似于它们在肝脏中的总体含量的浓度同时存在,导致糖脂半乳糖基转移酶、GL2和GM1合酶分别受到44%和64%的抑制。GM2合酶受到中度抑制,而唾液酸转移酶(GM3、GD3和GD1a合酶)几乎未受影响。D-半乳糖胺诱导的肝细胞损伤在大鼠肝脏匀浆和富含高尔基体的组分中测定时,并未引起糖基转移酶活性的任何变化。这些结果表明,UDP-氨基糖在给予GalN后体内观察到的神经节苷脂生物合成抑制中可能起作用。